Pain Relief Patches

Description

The product is identified by the SPL code 34089-3 and is classified as a pain relief patch. It is recommended to store the patch in a clean, dry environment, away from direct sunlight, and to protect it from excessive moisture to maintain its efficacy.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

For adults and children aged 12 years and over, the affected area should be cleaned and dried prior to application. The patch should be removed from its protective film and applied to the affected area. It is recommended that the patch be applied no more than 3 to 4 times daily. Each patch should be removed from the skin after a maximum application duration of 8 hours.

For children under 12 years of age, it is advised to consult a physician before use.

Contraindications

Use of this product is contraindicated in the following situations:

• Application on wounds or damaged skin is prohibited due to the potential for irritation and adverse effects.

• Concurrent use with a heating pad is contraindicated as it may increase the risk of burns or skin damage.

• Individuals with known allergies to any ingredients in this product should not use it to prevent allergic reactions.

Additionally, avoid contact with eyes, mucous membranes, or rashes, and do not apply tightly bandaged. The simultaneous use of other topical analgesics is also contraindicated to avoid potential interactions and increased risk of side effects.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to consult a doctor prior to use if they have a history of allergic reactions to aspirin or salicylates.

It is imperative to avoid application on wounds or damaged skin, as this may exacerbate the condition or lead to adverse effects. Additionally, the use of this product in conjunction with a heating pad is contraindicated, as it may increase the risk of skin irritation or burns. Patients should also be cautioned against using the product if they are allergic to any of its ingredients.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients should be instructed to discontinue use and consult a healthcare provider if they experience any of the following: rash, itching, or excessive skin irritation; worsening of their condition; or if symptoms persist for more than 7 days or resolve only to recur within a few days.

Side Effects

Patients should be aware of potential adverse reactions associated with the use of this medication. Individuals with a known allergy to aspirin or salicylates are advised to consult a healthcare professional prior to use to mitigate the risk of an allergic reaction.

In clinical practice, patients are instructed to discontinue use and seek medical advice if they experience any of the following symptoms: rash, itching, or excessive skin irritation. Additionally, if the condition being treated worsens or if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days, it is essential to consult a healthcare provider for further evaluation and management.

Drug Interactions

Concurrent use of this medication with other topical analgesics is contraindicated. The combination may increase the risk of adverse effects without providing additional therapeutic benefit. It is advised to avoid using multiple topical analgesics simultaneously to ensure patient safety and optimal therapeutic outcomes. Monitoring for any signs of increased local irritation or systemic effects is recommended if there is a concern about overlapping therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Pain Relief Patches (camphor, menthol, methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a physician prior to use. For adolescents aged 12 years and older, the recommended application involves cleaning and drying the affected area, followed by the removal of the patch from its film and application to the affected area. The patch may be applied no more than 3 to 4 times daily, with a maximum wear time of 8 hours per application.

It is crucial to dispose of used patches in a manner that prevents access by children and pets, as they still contain the drug product, which can lead to serious adverse effects if ingested. Additionally, the product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Safety during pregnancy has not been established for this medication. It is not recommended for use during pregnancy due to potential risks to the fetus. Pregnant patients or those planning to become pregnant should consult a healthcare provider before using this medication to discuss potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific details regarding overdosage for this medication (SPL code 34088-5), it is essential for healthcare professionals to remain vigilant and consider general principles of management in cases of suspected overdosage.

Recommended Actions In the event of an overdosage, healthcare providers should initiate appropriate supportive measures. This may include monitoring the patient's vital signs and providing symptomatic treatment as necessary. It is advisable to contact a poison control center or seek expert consultation for guidance tailored to the specific circumstances of the overdosage.

Potential Symptoms While specific symptoms associated with overdosage of this medication are not detailed, healthcare professionals should be aware that overdosage can lead to a range of adverse effects. Symptoms may vary based on the pharmacological properties of the drug and the individual patient's response.

Management Procedures Management of overdosage should be guided by the clinical presentation of the patient. Supportive care is paramount, and interventions may include the administration of activated charcoal if the patient presents within a suitable timeframe. Continuous monitoring and reassessment of the patient's condition are critical to ensure timely intervention and to mitigate potential complications.

In summary, while specific overdosage information is not provided, healthcare professionals should apply general overdosage management principles and remain alert to the potential for adverse effects.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is essential to instruct patients to use the product only as directed to ensure safety and efficacy.

Patients should be cautioned to avoid contact with the eyes, mucous membranes, or any rashes, as this may lead to irritation or adverse reactions. Additionally, healthcare providers should emphasize that patients must not bandage the area tightly, as this could affect the product's performance and increase the risk of side effects.

It is important to inform patients that they should not use this product concurrently with other topical analgesics, as this may lead to increased risk of adverse effects.

Finally, healthcare providers should instruct patients on the proper disposal of used patches. Used patches should be disposed of in a manner that prevents access by children and pets, as they still contain the drug product, which can cause serious adverse effects if ingested.

Storage and Handling

The product is supplied in a clean, dry package designed to protect it from direct sunlight and excessive moisture. It is essential to store the product in a location that meets these conditions to maintain its integrity and efficacy.

Healthcare professionals are advised to dispose of used patches responsibly. It is crucial to ensure that used patches are kept out of reach of children and pets, as they may still contain active drug components that could lead to serious adverse effects if ingested or chewed.

Additional Clinical Information

The route of administration for the product is topical. For adults and children aged 12 years and older, the affected area should be cleaned and dried before applying the patch, which can be used no more than 3 to 4 times daily. The patch should be removed after a maximum application time of 8 hours. For children under 12 years of age, consultation with a physician is advised prior to use.

Clinicians should counsel patients on several important safety measures. Patients with a history of allergic reactions to aspirin or salicylates should consult a doctor before use. Used patches must be disposed of properly to prevent accidental ingestion by children or pets, as they still contain active drug that can lead to serious adverse effects. Patients should discontinue use and seek medical advice if they experience rash, itching, excessive skin irritation, worsening of their condition, or if symptoms persist beyond 7 days or recur shortly after resolution. Additionally, the product should be kept out of reach of children, and immediate medical assistance should be sought if ingested.

Drug Information (PDF)

This file contains official product information for Pain Relief Patches, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)